Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:25:02 EDT Sat 20 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:GILD
- GILEAD SCIENCES INC -
http://www.gilead.com
08:25:02 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
GILD
- Q
9.0
66.20
·
66.90
9.2
66.76
+0.60
0.9
10,657.0
707,111
44,370
66.25
66.83
66.16
87.865 65.90
19:59:00
Apr 18
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Down
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 44370
More trades...
Time ET
Ex
Price
Change
Volume
19:59:00
Q
66.66
0.50
3
19:23:30
Q
66.76
0.60
1
19:18:53
Q
66.76
0.60
3
18:55:29
Q
66.76
0.60
35
18:20:10
Q
66.76
0.60
1
17:43:17
Q
66.75
0.59
20
17:27:52
Q
66.75
0.59
7
17:14:31
Q
66.66
0.50
1
17:03:15
Q
66.76
0.60
1
16:56:50
Q
66.76
0.60
50
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-18 13:47
U:GILD
News Release
200
Gilead Sciences Publishes 2023 ESG Impact Report
2024-04-08 16:05
U:GILD
News Release
200
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
2024-04-02 09:17
U:GILD
News Release
200
Gilead Sciences Champions Equal Pay
2024-03-28 08:30
U:GILD
News Release
200
FDA Expands Indication for Gilead's Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six
2024-03-28 07:00
U:GILD
News Release
200
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
2024-03-26 09:18
U:GILD
News Release
200
Winn Awards Help Physicians Solve Healthcare Disparities
2024-03-22 09:18
U:GILD
News Release
200
Gilead Sciences Announces Completion of Acquisition of CymaBay
2024-03-19 09:08
U:GILD
News Release
200
Gilead Helps Launch Turkiye's First HIV Testing Week
2024-03-18 19:29
U:GILD
News Release
200
Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant
2024-03-12 08:47
U:GILD
News Release
200
Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations
2024-03-11 08:24
U:GILD
News Release
200
Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer
2024-03-07 08:17
U:GILD
News Release
200
Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing
2024-03-06 16:30
U:GILD
News Release
200
Biktarvy(TM) Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities
2024-03-06 10:25
U:GILD
News Release
200
Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24
2024-03-06 08:00
U:GILD
News Release
200
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
2024-03-05 16:35
U:GILD
News Release
200
New Real-World Data Further Support the Use of Veklury(TM) (Remdesivir) for People Hospitalized With COVID-19
2024-03-05 16:30
U:GILD
News Release
200
Gilead's Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health
2024-03-05 08:47
U:GILD
News Release
200
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
2024-02-29 08:33
U:GILD
News Release
200
Gilead Sciences: National Black HIV/AIDS Awareness Day